CBAY

Cymabay Therapeutics

Delisted

CBAY was delisted on the 21st of March, 2024.

151 hedge funds and large institutions have $1.02B invested in Cymabay Therapeutics in 2023 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 42 increasing their positions, 39 reducing their positions, and 32 closing their positions.

Holders
151
Holders Change
+12
Holders Change %
+8.63%
% of All Funds
2.38%
Holding in Top 10
9
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-10%
% of All Funds
0.14%
New
45
Increased
42
Reduced
39
Closed
32
Calls
$3.85M
Puts
$225K
Net Calls
+$3.62M
Net Calls Change
+$531K
Name Holding Trade Value Shares
Change
Shares
Change %
PCM
176
Prelude Capital Management
New York
-$95.7K -10,973 Closed
LIP
177
Lighthouse Investment Partners
Florida
-$88K -10,092 Closed
SPIA
178
Steward Partners Investment Advisory
New York
-$4.36K -500 Closed
US Bancorp
179
US Bancorp
Minnesota
-$3.14K -360 Closed
TWA
180
TCI Wealth Advisors
Arizona
-$2.97K -341 Closed
Creative Planning
181
Creative Planning
Kansas
-$2.02K -231 Closed
PA
182
Parallel Advisors
California
-$358 -41 Closed
Man Group
183
Man Group
United Kingdom
-$159K